Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells

Rong Lu, Ling Song, Richard S Jope

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

LITHIUM has neuroprotective effects in a number of model systems which may contribute to the therapeutic effects of lithium in mood disorders. Because the tumor suppressor p53 is linked to cell death, we tested whether lithium administration to human neuroblastoma SHSY5Y cells modulated the activation of p53. After treatment of cells with H7 (25, 50, and 75 μM), nuclear p53 levels were increased to 464, 816 and 1079% of basal levels, respectively. A 24h pretreatment with 5mM lithium reduced these increases by 69, 61 and 28%, respectively. Pretreatment with 2 mM lithium for I or 14 days reduced the 25 μM H7-induced elevations of nuclear p53 by 40 and 70%, respectively, and even a 14-day pretreatment with 1 mM lithium caused a significant 16% reduction. Since increased nuclear p53 is a critical intermediate step in many signaling processes that culminate in cell death, attenuation of p53 activation by lithium reveals a mechanism by which lithium may support neuronal survival.

Original languageEnglish
Pages (from-to)1123-1125
Number of pages3
JournalNeuroReport
Volume10
Issue number5
StatePublished - Apr 6 1999
Externally publishedYes

Fingerprint

Neuroblastoma
Lithium
Cell Death
Neuroprotective Agents
Therapeutic Uses
Mood Disorders
Neoplasms

Keywords

  • Apoptosis
  • Bipolar disorder
  • H7
  • Lithium
  • Neuroblastoma
  • P53
  • SH-SY5Y

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. / Lu, Rong; Song, Ling; Jope, Richard S.

In: NeuroReport, Vol. 10, No. 5, 06.04.1999, p. 1123-1125.

Research output: Contribution to journalArticle

Lu, Rong ; Song, Ling ; Jope, Richard S. / Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. In: NeuroReport. 1999 ; Vol. 10, No. 5. pp. 1123-1125.
@article{8e5826abcc104a94b41e481daead4e88,
title = "Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells",
abstract = "LITHIUM has neuroprotective effects in a number of model systems which may contribute to the therapeutic effects of lithium in mood disorders. Because the tumor suppressor p53 is linked to cell death, we tested whether lithium administration to human neuroblastoma SHSY5Y cells modulated the activation of p53. After treatment of cells with H7 (25, 50, and 75 μM), nuclear p53 levels were increased to 464, 816 and 1079{\%} of basal levels, respectively. A 24h pretreatment with 5mM lithium reduced these increases by 69, 61 and 28{\%}, respectively. Pretreatment with 2 mM lithium for I or 14 days reduced the 25 μM H7-induced elevations of nuclear p53 by 40 and 70{\%}, respectively, and even a 14-day pretreatment with 1 mM lithium caused a significant 16{\%} reduction. Since increased nuclear p53 is a critical intermediate step in many signaling processes that culminate in cell death, attenuation of p53 activation by lithium reveals a mechanism by which lithium may support neuronal survival.",
keywords = "Apoptosis, Bipolar disorder, H7, Lithium, Neuroblastoma, P53, SH-SY5Y",
author = "Rong Lu and Ling Song and Jope, {Richard S}",
year = "1999",
month = "4",
day = "6",
language = "English",
volume = "10",
pages = "1123--1125",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells

AU - Lu, Rong

AU - Song, Ling

AU - Jope, Richard S

PY - 1999/4/6

Y1 - 1999/4/6

N2 - LITHIUM has neuroprotective effects in a number of model systems which may contribute to the therapeutic effects of lithium in mood disorders. Because the tumor suppressor p53 is linked to cell death, we tested whether lithium administration to human neuroblastoma SHSY5Y cells modulated the activation of p53. After treatment of cells with H7 (25, 50, and 75 μM), nuclear p53 levels were increased to 464, 816 and 1079% of basal levels, respectively. A 24h pretreatment with 5mM lithium reduced these increases by 69, 61 and 28%, respectively. Pretreatment with 2 mM lithium for I or 14 days reduced the 25 μM H7-induced elevations of nuclear p53 by 40 and 70%, respectively, and even a 14-day pretreatment with 1 mM lithium caused a significant 16% reduction. Since increased nuclear p53 is a critical intermediate step in many signaling processes that culminate in cell death, attenuation of p53 activation by lithium reveals a mechanism by which lithium may support neuronal survival.

AB - LITHIUM has neuroprotective effects in a number of model systems which may contribute to the therapeutic effects of lithium in mood disorders. Because the tumor suppressor p53 is linked to cell death, we tested whether lithium administration to human neuroblastoma SHSY5Y cells modulated the activation of p53. After treatment of cells with H7 (25, 50, and 75 μM), nuclear p53 levels were increased to 464, 816 and 1079% of basal levels, respectively. A 24h pretreatment with 5mM lithium reduced these increases by 69, 61 and 28%, respectively. Pretreatment with 2 mM lithium for I or 14 days reduced the 25 μM H7-induced elevations of nuclear p53 by 40 and 70%, respectively, and even a 14-day pretreatment with 1 mM lithium caused a significant 16% reduction. Since increased nuclear p53 is a critical intermediate step in many signaling processes that culminate in cell death, attenuation of p53 activation by lithium reveals a mechanism by which lithium may support neuronal survival.

KW - Apoptosis

KW - Bipolar disorder

KW - H7

KW - Lithium

KW - Neuroblastoma

KW - P53

KW - SH-SY5Y

UR - http://www.scopus.com/inward/record.url?scp=0033528817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033528817&partnerID=8YFLogxK

M3 - Article

C2 - 10321495

AN - SCOPUS:0033528817

VL - 10

SP - 1123

EP - 1125

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 5

ER -